Clarius Group LLC Has $3.57 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Clarius Group LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,053 shares of the healthcare conglomerate’s stock after buying an additional 441 shares during the period. Clarius Group LLC’s holdings in UnitedHealth Group were worth $3,568,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in UNH. Oak Ridge Investments LLC boosted its holdings in shares of UnitedHealth Group by 5.6% during the 4th quarter. Oak Ridge Investments LLC now owns 41,946 shares of the healthcare conglomerate’s stock worth $21,219,000 after buying an additional 2,227 shares during the period. HF Advisory Group LLC increased its stake in shares of UnitedHealth Group by 5.3% in the fourth quarter. HF Advisory Group LLC now owns 1,263 shares of the healthcare conglomerate’s stock worth $639,000 after purchasing an additional 64 shares during the period. Aaron Wealth Advisors LLC grew its holdings in UnitedHealth Group by 7.7% in the 4th quarter. Aaron Wealth Advisors LLC now owns 4,468 shares of the healthcare conglomerate’s stock valued at $2,260,000 after buying an additional 318 shares during the last quarter. Sandy Cove Advisors LLC lifted its holdings in shares of UnitedHealth Group by 6.7% during the fourth quarter. Sandy Cove Advisors LLC now owns 1,051 shares of the healthcare conglomerate’s stock worth $532,000 after buying an additional 66 shares during the last quarter. Finally, Bowman & Co S.C. grew its stake in shares of UnitedHealth Group by 28.0% in the fourth quarter. Bowman & Co S.C. now owns 3,936 shares of the healthcare conglomerate’s stock worth $1,997,000 after acquiring an additional 861 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

Shares of UNH opened at $510.03 on Friday. The stock’s fifty day simple moving average is $549.37 and its 200-day simple moving average is $562.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $469.37 billion, a PE ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the company earned $5.83 EPS. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. KeyCorp restated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research report on Friday. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday. Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Oppenheimer increased their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.